Bahamas vs Libya: Cause of death, by non-communicable diseases, ages 15-59, male
Bahamas
48.1%
in 2021
Libya
47.6%
in 2021
Bahamas rank
101st
Libya rank
104th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Bahamas
- Libya
How they compare
Bahamas currently reports 48.1% against 47.6% in Libya, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Libya ahead.
Bahamas ranks 101st and Libya ranks 104th of 185 countries.
Across the 3 decades both report, Bahamas averaged higher in 2 and Libya in 1.
Head to head by decade
| Decade | Bahamas | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.1% | 50.7% | 6.5% | Libya |
| 2010s | 56.1% | 47.7% | 8.4% | Bahamas |
| 2020s | 51.2% | 47.8% | 3.5% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Bahamas or Libya?
- Bahamas, at 48.1% against 47.6% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Bahamas and Libya?
- 0.5%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahamas and Libya rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Bahamas ranks 101st and Libya ranks 104th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.